Moderna
MRNA
#1601
Rank
A$16.44 B
Marketcap
$42.54
Share price
-0.62%
Change (1 day)
-73.97%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2024 (TTM): -A$5.54 Billion

According to Moderna 's latest financial reports the company's current earnings are A$3.19 Billion. , an increase over its 2023 earnings that were of -A$6.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2024

Annual earnings

Year Earnings Change
2024 -A$5.61 Billion-8.22%
2023 -A$6.11 Billion-140.65%
2022 A$15.01 B-27.81%
2021 A$20.79 B-1911.15%
2020 -A$1.15 Billion44.7%
2019 -A$0.8 Billion28.63%
2018 -A$0.62 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$72.22 Million-98.71%๐Ÿ‡บ๐Ÿ‡ธ USA
A$33.14 B-691.88%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$65.28 Million-98.83%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.37 Billion-93.43%๐Ÿ‡บ๐Ÿ‡ธ USA
A$21.31 B-480.69%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-A$0.94 Billion-83.25%๐Ÿ‡บ๐Ÿ‡ธ USA
A$27.26 B-586.80%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.19 Billion-96.72%๐Ÿ‡บ๐Ÿ‡ธ USA